PRECISION BIOSCIENCES INC — Director's Dealing 2019

Sep 25, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-09-23

Reporting Person: JANTZ DEREK (Director, Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-23	Employee Stock Option (Right to Buy)	$9.46	A	52651	Acquired	2029-09-22	Common Stock (52651)	Direct

Footnotes

F1: The option vests as to 25% of the underlying shares on April 1, 2020 and vests in equal installments at the end of each successive three-month period over the 36 months following such date.